Although a slight trend appeared toward negative effects of biologic treatment in patients with atopic and T2-high asthma and positive effects in those with eosinophilic asthma, no outcome was statistically significantly affected by biologic exposure.
← all excerpts
Asthma and COVID-19: Unveiling Outcome Disparities and Treatment Impact Based on Distinct Endotypes.
1
—
—